Related Experiment Video
Updated: Mar 25, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
[Changes in gut microbiota and serum D-lactate level and correlation analysis in children with recurrent pneumonia]
Shao Peng1, Tian-Hua DU, Man Zhang
1Department of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China. pengshaodh630@126.com.
Insights
Children with recurrent pneumonia exhibit altered gut microbiota, with lower Bifidobacterium and higher Escherichia coli. This imbalance correlates with elevated serum D-lactate, suggesting intestinal barrier dysfunction.
Area of Science:
- Pediatric Pulmonology
- Microbiome Research
- Gastroenterology
Background:
- Recurrent pneumonia in children poses a significant health challenge.
- Gut microbiota dysbiosis is increasingly linked to various pediatric diseases.
- Intestinal barrier integrity is crucial for maintaining systemic health.
Purpose of the Study:
- To investigate gut microbiota composition and serum D-lactate levels in children with recurrent pneumonia.
- To determine the correlation between gut microbiota alterations and elevated D-lactate in this population.
- To explore the implications for intestinal barrier function in recurrent pneumonia.
Main Methods:
- Collected stool and blood samples from children with recurrent pneumonia, acute pneumonia, and a control surgery group.
- Utilized 16S rRNA fluorescent quantitative polymerase chain reaction (FQ-PCR) to quantify Bifidobacterium and Escherichia coli.
- Calculated the Bifidobacterium/Escherichia coli (B/E) ratio and measured serum D-lactate levels, followed by correlation analysis.
Main Results:
- Children with recurrent pneumonia showed significantly lower Bifidobacterium counts and B/E ratios compared to controls.
- Elevated Escherichia coli counts were observed in the recurrent group versus the surgery group.
- Serum D-lactate levels were significantly higher in children with recurrent pneumonia, negatively correlating with the B/E ratio.
Conclusions:
- Recurrent pneumonia in children is associated with significant gut dysbiosis, characterized by reduced beneficial bacteria and increased potentially harmful bacteria.
- Increased serum D-lactate levels in these children suggest compromised intestinal barrier function.
- These findings indicate potential biological and mechanical barrier damage in the intestinal mucosa of children with recurrent pneumonia.
Objective:
To study the changes in gut microbiota and serum D-lactate level and their significance in children with recurrent pneumonia.
Methods:
The stool and blood samples were collected from 30 children with recurrent pneumonia (recurrent group), 30 children with acute pneumonia (acute group), and 15 children receiving surgical operation (surgery group). The 16S rRNA fluorescent quantitative polymerase chain reaction (FQ-PCR) was applied to determine the numbers of Bifidobacterium and Escherichia coli in stool samples, and the ratio between the logarithmic values of the numbers of Bifidobacterium and Escherichia coli (B/E value) was calculated. The serum D-lactate level was measured, and correlation analysis was performed.
Results:
The recurrent group had a significantly lower number of Bifidobacterium and a significantly lower B/E value than the acute group and the surgery group (P<0.05), as well as a significantly higher number of Escherichia coli than the surgery group (P<0.05). There was no significant difference in the number of Escherichia coli between the recurrent group and the acute group. The recurrent group had a significantly higher serum D-lactate level than the acute group and the surgery group (P<0.05). In the recurrent group, B/E value was negatively correlated with serum D-lactate level (r=-0.539, P<0.05).
Conclusions:
Children with recurrent pneumonia may have biological and mechanical barrier damage in the intestinal mucosa.
Related Concept Videos
Development of Human Microbiota
Microbiota of the Respiratory Tract
Microbiota of the Stomach and Small Intestine
Development of the Oral Microbiota
Serum Laboratory Studies, Stool Test, Breath Test
Pneumonia III: Complications and Assessment

